Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention ...
AI in software engineering— a loose, vibes-based approach has given way to a systematic approach to managing how AI systems ...
4h
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
Phase 3 LUGANO and LUCIA clinical trials for DURAVYU™ in wet AMD fully enrolled and on track for data readout beginning in mid-2026 –– ...
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback